Qube Research & Technologies LTD Horizon Therapeutics Public LTD CO Transaction History

Qube Research & Technologies LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $15.6 Million - $18.3 Million	157,987 Added 27.75%	727,409 $84.2 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $9.28 Million - $10.8 Million	-96,363 Reduced 14.47%	569,422 $58.6 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $71.5 Million - $75.6 Million	665,785 New	665,785 $72.7 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $22 Million - $31.7 Million	-374,095 Reduced 58.36%	266,931 $16.5 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $23.3 Million - $34.2 Million	293,952 Added 84.69%	641,026 $51.1 Million
Q1 2022 May 09, 2022	BUY	$86.42 - $109.81 $7.37 Million - $9.36 Million	85,232 Added 32.55%	347,074 $36.5 Million
Q4 2021 Feb 01, 2022	BUY	$98.56 - $119.91 $25.8 Million - $31.4 Million	261,842 New	261,842 $28.2 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $1.56 Million - $1.73 Million	-18,045 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $1.3 Million - $1.72 Million	18,045 New	18,045 $1.66 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $7.9 Million - $9.95 Million	-117,952 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $5.2 Million - $7.52 Million	94,062 Added 393.73%	117,952 $9.16 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $721,478 - $1.36 Million	23,890 New	23,890 $1.33 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.